Kurs
-1,70%
Kurs
-1,70%
Open
1060,00
High
1060,00
Low
1028,00
Close
1040,00
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
1,83 MNOK
Likviditet
1,83 MNOK
Rel. mcap
0,63%
Antal aktier
1 757
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2026-02-12 | 07:30 | Bokslutskommuniké 2025 |
| 2025-11-06 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-20 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-29 | - | Årsstämma |
| 2025-04-24 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2025-04-01 | - | Split ZLNA 10:1 |
| 2025-01-31 | - | Bokslutskommuniké 2024 |
| 2025-01-09 | - | Extra Bolagsstämma 2025 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-25 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2024-04-24 | - | Årsstämma |
| 2024-02-14 | - | Bokslutskommuniké 2023 |
| 2023-11-08 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-21 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2023-04-20 | - | Årsstämma |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-21 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2022-04-20 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-22 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2021-04-21 | - | Årsstämma |
| 2021-02-17 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-11-11 | - | Extra Bolagsstämma 2020 |
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-16 | - | X-dag ordinarie utdelning ZLNA 0.00 NOK |
| 2020-04-15 | - | Årsstämma |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-14 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2022-02-10 08:00:00
Oslo, 10 February 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical
stage leader in immune stimulatory vaccines for cancer, invites to a webcast
presentation of its fourth quarter 2021 results on Thursday 17 February 2022.
The presentation can be followed as a live webcast accessed through a link on
www.ultimovacs.com (http://www.ultimovacs.com) at 09:00 CET on Thursday 17
February 2022. The webcast presentation will be available on the Ultimovacs
website, and it will be possible to post questions during the presentation
through the webcast.
The report and presentation will be available on the company website from 08:00
CET the same day.
For further information, please see www.ultimovacs.com
(http://www.ultimovacs.com) or contact:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com (mailto:carlos.desousa@ultimovacs.com)
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com (mailto:hans.eid@ultimovacs.com)
Phone: +47 482 48632
Anne Worsøe, Head of IR & Communication
Email: anne.worsoe@ultimovacs.com (mailto:anne.worsoe@ultimovacs.com)
Phone: +47 906 86815
Mary-Ann Chang, LifeSci Advisors
Email: mchang@lifesciadvisors.com (mailto:mchang@lifesciadvisors.com)
Phone: +44 7483 284 853